Ezetimibe Impurity 7 | CAS 1607018-80-3 - Request Quote
Ezetimibe Impurity 7
| SZ CAT No: | SZ-E026057 |
| CAS No | 1607018-80-3 |
| Mol.F. | C26H24FNO4 |
| Mol.Wt. | 433.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ezetimibe Impurity 7 is chemically Methyl 3-((2R,3R)-2-(4-(benzyloxy)phenyl)-1-(4-fluorophenyl)-4-oxoazetidin-3-yl)propanoate. Ezetimibe Impurity 7 is supplied with detailed characterization data compliant with regulatory guideline. Ezetimibe Impurity 7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ezetimibe.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1607018-80-3
Purchase 1607018-80-3
Order 1607018-80-3
Enquire 1607018-80-3
price of 1607018-80-3
1607018-80-3 Supplier
1607018-80-3 Manufacturer
1607018-80-3 Exporter
buy high quality Ezetimibe Impurity 7
Purchase Ezetimibe Impurity 7
Ezetimibe Impurity 7 suppliers
Ezetimibe Impurity 7 manufacturers
Ezetimibe Impurity 7 price
Order Ezetimibe Impurity 7
Enquire Ezetimibe Impurity 7
Ezetimibe Impurity 7 cost
Ezetimibe Impurity 7 Supplier
Ezetimibe Impurity 7 Distributor
Ezetimibe Impurity 7 for Method Validation
Ezetimibe Reference Standard
Ezetimibe Impurity 7 for ANDA Filing
Ezetimibe Impurity 7 for Forced Degradation Studies
Ezetimibe Impurity 7 Identification Standards
Ezetimibe Impurity 7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.